Rhythm Pharmaceuticals, Inc. (RYTM)
111.44
+1.44
(+1.31%)
USD |
NASDAQ |
Aug 24, 16:00
111.41
-0.03
(-0.03%)
After-Hours: 20:00
Rhythm Pharmaceuticals 1 Year Total Returns (Daily) : 7.91% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 7.91% |
| August 21, 2026 | 8.18% |
| August 20, 2026 | 10.35% |
| August 19, 2026 | 19.08% |
| August 18, 2026 | 17.49% |
| August 17, 2026 | 18.27% |
| August 14, 2026 | 19.69% |
| August 13, 2026 | 18.56% |
| August 12, 2026 | 21.92% |
| August 11, 2026 | 19.65% |
| August 10, 2026 | 25.55% |
| August 07, 2026 | 25.03% |
| August 06, 2026 | 24.54% |
| August 05, 2026 | 25.00% |
| August 04, 2026 | 17.22% |
| August 03, 2026 | 16.40% |
| July 31, 2026 | 16.45% |
| July 30, 2026 | 24.90% |
| July 29, 2026 | 24.41% |
| July 28, 2026 | 26.10% |
| July 27, 2026 | 22.76% |
| July 24, 2026 | 16.99% |
| July 23, 2026 | 16.91% |
| July 22, 2026 | 18.39% |
| July 21, 2026 | 20.28% |
| Date | Value |
|---|---|
| July 20, 2026 | 17.26% |
| July 17, 2026 | 17.56% |
| July 16, 2026 | 16.02% |
| July 15, 2026 | 22.75% |
| July 14, 2026 | 23.34% |
| July 13, 2026 | 23.98% |
| July 10, 2026 | 21.74% |
| July 09, 2026 | 29.75% |
| July 08, 2026 | 75.67% |
| July 07, 2026 | 72.41% |
| July 06, 2026 | 69.80% |
| July 02, 2026 | 70.61% |
| July 01, 2026 | 68.72% |
| June 30, 2026 | 75.71% |
| June 29, 2026 | 75.42% |
| June 26, 2026 | 78.76% |
| June 25, 2026 | 73.80% |
| June 24, 2026 | 68.94% |
| June 23, 2026 | 70.92% |
| June 22, 2026 | 63.56% |
| June 18, 2026 | 57.43% |
| June 17, 2026 | 54.64% |
| June 16, 2026 | 43.81% |
| June 15, 2026 | 42.61% |
| June 12, 2026 | 40.24% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 15.19% |
| Aprea Therapeutics, Inc. | -51.05% |
| Alnylam Pharmaceuticals, Inc. | -48.06% |
| Anika Therapeutics, Inc. | 121.1% |
| Savara, Inc. | 75.95% |